Trial intelligence / Profile preview

Regional citrate anticoagulation hemodialysis with two ionized calcium targets

ACTRN12613001029785Phase 4Completed

Sponsor
University Medical Centre Ljubljana
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of trisodium citrate in chronic kidney disease (CKD) (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Calcium mass balance. Started Jan 2014; status: completed.

02

Drugs

trisodium citrate
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on ACTRN12613001029785.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613001029785.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call